MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) is advancing a voice-based artificial intelligence platform designed to detect drug and alcohol impairment in real time from short speech samples. The technology, which analyzes over 140 acoustic markers trained on more than 50 million data points, offers a non-invasive alternative to traditional breath, saliva, urine and laboratory-based testing. According to the company, the AI model can predict alcohol intoxication with remarkable accuracy using only the human voice.
The platform is being developed for deployment through Edge AI kiosks, with initial field testing planned in 2026. MindBio’s first commercial focus is on South American mining operations, where large-scale workforce screening presents significant safety and logistical challenges. The mining industry, along with aviation, construction, transportation, law enforcement, call centers and healthcare, represents a substantial addressable market for the technology.
The global alcohol and drug testing devices market is projected to grow from approximately $2.5 billion in 2025 to $4.2 billion by 2033, according to industry estimates. MindBio aims to capitalize on this growth by providing a faster, scalable solution for workplace impairment detection. The company’s proprietary research supports the development of an enterprise platform that integrates bespoke hardware and software for detecting intoxication via voice analysis.
MindBio’s technology addresses the increasing demand for rapid and non-invasive testing methods. Traditional testing methods often require sample collection and laboratory analysis, which can be time-consuming and logistically burdensome for large workforces. In contrast, voice-based analysis can deliver results in real time, enabling immediate safety interventions. The platform’s ability to analyze speech samples through Edge AI kiosks also enhances privacy and reduces the need for specialized personnel to administer tests.
Beyond mining, MindBio sees opportunities to expand into other sectors where impairment detection is critical for safety. The aviation, construction and transportation industries, for example, require rigorous testing to prevent accidents. Law enforcement agencies could also use the technology for roadside sobriety checks, while call centers and healthcare facilities may adopt it to ensure employee fitness for duty.
The company is leveraging its AI prediction model, which uses over 50 million data points to predict alcohol intoxication. This extensive dataset allows the model to identify subtle acoustic markers associated with impairment, providing a high degree of accuracy. MindBio is developing the platform as a comprehensive enterprise solution that includes Edge AI kiosks, which process voice samples locally to ensure fast response times and data security.
As MindBio progresses toward field testing, the company is positioning itself to address the evolving needs of workplace safety and regulatory compliance. The non-invasive nature of voice analysis, combined with its potential for real-time assessment, could transform how industries manage impairment detection. With the global testing market expanding, MindBio’s technology represents a promising innovation in the field of occupational health and safety.
